Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-067022
Filing Date
2014-11-06
Accepted
2014-11-06 16:39:31
Documents
1
Period of Report
2014-11-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4145
  Complete submission text file 0001209191-14-067022.txt   5496
Mailing Address C/O SUPERGEN, INC. 4140 DUBLIN BLVD., SUITE 200 DUBLIN CA 94568
Business Address
AZAB MOHAMMAD (Reporting) CIK: 0001309653 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 141201319

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations